Press release
Genomics Market Share is Expected to Witness Healthy Valuation of USD 133.84 Billion at 12.60% CAGR by 2032
The genomics market is experiencing rapid growth and transformation, propelled by advancements in genetic research, personalized medicine, and the declining cost of genomic sequencing technologies. This burgeoning field offers insights into the genetic basis of diseases, driving demand for genomic solutions across various sectors.The genomics market is projected to reach USD 133.84 billion by 2032 at 12.60% CAGR during the forecast period 2023-2032, driving market growth is the expanding applications of genomics in healthcare. Genomic testing enables personalized treatment plans, leading to improved patient outcomes and reduced healthcare costs. Additionally, the integration of genomics into clinical practice facilitates early disease detection, enabling timely interventions and preventive measures.
Get Free Sample PDF Brochure: https://www.marketresearchfuture.com/sample_request/12283
Market Competitive Analysis:
The genomics market includes some of the prominent players like-
Agilent Technologies
Bio-Rad Laboratories Inc.
BGI Genomics
Color Genomics Inc.
Danaher Corporation
Eppendorf AG
Eurofins Scientific
Hoffmann-La Roche Ltd.
GE Healthcare
Illumina Inc.
Myriad Genetics, Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
23andMe Inc.
Market Segment Analysis:
The global genomics market has been segmented based application & technology, end-use and deliverables.
On the basis of application & technology, the market is segmented into Functional Genomics, Epigenomics, Pathway Analysis and Biomarker Discovery.
Based on end-use, the global genomics market has been segmented into Clinical Research, Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End Users.
Based on deliverables, the global market has been segmented into Products and Services.
Genomics Market Trends:
Drivers
The shift towards personalized medicine and targeted therapies is fueling demand for genomic testing and analysis. Genomic information enables healthcare providers to tailor treatment plans based on individual genetic profiles, improving treatment efficacy and patient outcomes.
Buy Now Premium Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=12283
The growing prevalence of genetic disorders, chronic diseases, and cancer is driving the demand for genomic testing for early diagnosis, risk assessment, and treatment planning. Genomic screening and testing play a crucial role in identifying genetic predispositions and guiding preventive measures and therapeutic interventions.
Restraints
The genomics market is subject to complex and evolving regulatory frameworks governing genetic testing, data sharing, and research involving human subjects. Compliance with regulatory requirements, including those related to data privacy, quality assurance, and ethical standards, can pose barriers to market entry and innovation.
Market Regional Analysis:
North America leads the global genomics market, driven by significant investments in research and development, robust healthcare infrastructure, and supportive regulatory frameworks. The United States, in particular, boasts a thriving ecosystem of genomics companies, research institutions, and academic centers.
Europe emerges as a key player in the genomics landscape, characterized by progressive policies, collaborative research initiatives, and growing adoption of genomic medicine. Countries like the United Kingdom, Germany, and France spearhead genomic research and clinical applications, leveraging large-scale biobanks and population-based studies.
Browse In-depth Market Research Report (134 Pages) on Genomics Market: https://www.marketresearchfuture.com/reports/genomics-market-12283
The Asia-Pacific region witnesses rapid growth in the genomics market, fueled by advancements in biotechnology, increasing healthcare expenditure, and rising demand for personalized medicine.
Latin America demonstrates a burgeoning interest in genomics, driven by a growing awareness of its potential in healthcare. Countries like Brazil, Mexico, and Argentina invest in genomics research, albeit at a slower pace compared to other regions.
Africa is at the nascent stage of genomics adoption, yet holds immense potential for genetic research and precision medicine applications. Initiatives like the Human Heredity and Health in Africa (H3Africa) project aim to build genomic research capacity and address health disparities on the continent.
Related Reports:
Coronary Artery Bypass Graft Market - https://www.marketresearchfuture.com/reports/coronary-artery-bypass-graft-market-2285
Fetal Bovine Serum Market - https://www.marketresearchfuture.com/reports/fetal-bovine-serum-market-7377
Necrotising Enterocolitis Market - https://www.marketresearchfuture.com/reports/necrotising-enterocolitis-market-5999
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomics Market Share is Expected to Witness Healthy Valuation of USD 133.84 Billion at 12.60% CAGR by 2032 here
News-ID: 3445632 • Views: …
More Releases from Market Research Future - MRFR
India Commercial Real Estate Market Expected to Achieve a Strong 21.6% CAGR, to …
The India commercial real estate market plays a vital role in the country's economic development, supporting business expansion, employment generation, and urban infrastructure growth. Commercial real estate includes office spaces, retail properties, logistics and warehousing facilities, business parks, and mixed-use developments. Over the past decade, the sector has evolved significantly, driven by rapid urbanization, growth of the services sector, foreign investments, and improvements in regulatory frameworks.
According to Market Research Future…
Stainless Steel Market Forecasted to Reach USD 65781.38 Billion By 2035, at an I …
Stainless steel is a corrosion-resistant alloy primarily composed of iron, chromium, and varying amounts of nickel, molybdenum, and other elements. Its defining characteristic is its ability to resist rust and staining, which makes it suitable for a wide range of applications across industries. Stainless steel offers a combination of strength, durability, hygiene, and aesthetic appeal, making it a preferred material in construction, automotive, food processing, medical equipment, and industrial manufacturing.
According…
Malaysia Construction Market Projected to Reach USD 127.69 Billion, with a Robus …
The construction sector plays a vital role in Malaysia's economic development, contributing significantly to employment generation, infrastructure growth, and urban expansion. The Malaysia construction market encompasses residential, commercial, industrial, and infrastructure development, supported by both public and private investments. As the country continues to advance its urbanization goals and strengthen connectivity, construction activities remain a key pillar of national progress.
According to Market Research Future analysis, the Malaysia Construction Market was…
Europe Biochar Market Expected to Hit USD 603.9 Million by 2035 with a Remarkabl …
Biochar is a carbon-rich material produced through the pyrolysis of biomass under limited oxygen conditions. It is widely recognized for its ability to improve soil health, enhance agricultural productivity, sequester carbon, and support sustainable waste management. In Europe, biochar has gained significant attention as part of the region's broader commitment to climate neutrality, circular economy principles, and sustainable agriculture.
According to Market Research Future analysis, the Europe biochar market Size was…
More Releases for Genomic
Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),…
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025
As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad
Japan: Recent Industry Developments
✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in…
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"
Genomic & Epigenomic Profiling Market Size is…
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
